Skip to main content

Domain

A hydrophobic region that gives rise to the prediction of a transmembrane span does not cross the membrane, but is part of a discontinuously helical region that dips into the membrane and is probably part of the pore and of the selectivity filter.

The extracellular N-terminal domain (NTD) is a site of allosteric regulation to modulate overall receptor function.

The ligand-binding domain (LBD) binds to glycine (GluN1 and GluN3 subunits) and glutamate (GluN2 subunits) and control opening of the channel gate.

The transmembrane domain (TMD) harbors the channel gate and pore.

Function

Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:21376300, PubMed:26875626, PubMed:26919761, PubMed:28126851, PubMed:28228639, PubMed:36959261, PubMed:7679115, PubMed:7681588, PubMed:7685113). NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the long-term potentiation (LTP) (PubMed:26875626). Channel activation requires binding of the neurotransmitter L-glutamate to the GluN2 subunit, glycine or D-serine binding to the GluN1 subunit, plus membrane depolarization to eliminate channel inhibition by Mg(2+) (PubMed:21376300, PubMed:26875626, PubMed:26919761, PubMed:27164704, PubMed:28095420, PubMed:28105280, PubMed:28126851, PubMed:28228639, PubMed:36959261, PubMed:38538865, PubMed:7679115, PubMed:7681588, PubMed:7685113). NMDARs mediate simultaneously the potasium efflux and the influx of calcium and sodium (By similarity). Each GluN2 or GluN3 subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, Ca2(+) permeability, and binding to allosteric modulators (PubMed:26875626, PubMed:26919761, PubMed:36309015, PubMed:38598639).

Involvement in disease

Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant

NDHMSD

An autosomal dominant neurodevelopmental disorder characterized by severe intellectual disability and developmental delay, absent speech, muscular hypotonia, dyskinesia, and hyperkinetic movements. Cortical blindness, cerebral atrophy, and seizures are present in some patients.

None

The disease is caused by variants affecting the gene represented in this entry.

Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive

NDHMSR

An autosomal recessive neurodevelopmental disorder characterized by severe intellectual disability and psychomotor developmental delay, involuntary and stereotypic movements, spasticity, and inability to walk without support. Intractable seizures manifest in some patients.

None

The disease is caused by variants affecting the gene represented in this entry.

Developmental and epileptic encephalopathy 101

DEE101

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE101 is an autosomal recessive, severe form characterized by onset of seizures in early infancy. Death in infancy may occur.

None

The disease is caused by variants affecting the gene represented in this entry.

Post-translational modifications

NMDA is probably regulated by C-terminal phosphorylation of an isoform of GRIN1 by PKC (PubMed:8316301). Dephosphorylated on Ser-897 probably by protein phosphatase 2A (PPP2CB) (PubMed:8316301). Its phosphorylated state is influenced by the formation of the NMDAR-PPP2CB complex and the NMDAR channel activity (PubMed:8316301).

Sequence similarities

Belongs to the glutamate-gated ion channel (TC 1.A.10.1) family. NR1/GRIN1 subfamily.

Cellular localization

  • Cell membrane
  • Multi-pass membrane protein
  • Postsynaptic cell membrane
  • Postsynaptic density membrane
  • Synaptic cell membrane
  • Synaptic cell membrane targeting is dependent of GRIN2B/GluN2B subunit (By similarity). Association with GRIN3A occurs in the endoplasmic reticulum (By similarity).

Alternative names

NMDAR1, GRIN1, GluN1, Glutamate [NMDA] receptor subunit zeta-1, N-methyl-D-aspartate receptor subunit NR1, NMD-R1, hNR1

Target type

Proteins

Primary research area

Neuroscience

Other research areas

  • Cardiovascular

Molecular weight

105373Da

We found 16 products in 2 categories

Proteins & Peptides

Target

Species of origin

Search our catalogue for 'Grin1' (16)

Products

ab109182

Anti-NMDAR1 antibody [EPR2481(2)]

Recombinant
RabMAb
KO Validated
20ul selling size

ab274377

Anti-NMDAR1 antibody [EPR23397-66]

Recombinant
RabMAb
KO Validated
20ul selling size

ab68144

Anti-NMDAR1 antibody [EPR2480Y] - Neuronal Marker

Lab Essentials
Recombinant
RabMAb
Advanced Validation
KO Validated
20ul selling size

ab274390

Anti-NMDAR1 antibody [EPR23397-66] - BSA and Azide free

Recombinant
RabMAb
KO Validated

ab239949

Anti-NMDAR1 antibody [EPR2481(2)] - BSA and Azide free

Recombinant
RabMAb
KO Validated

ab317939

APC Anti-NMDAR1 antibody [EPR2481(2)]

Recombinant
RabMAb

ab317899

PE Anti-NMDAR1 antibody [EPR2481(2)]

Recombinant
RabMAb